What is the recommended dosage of Clarithromycin (generic name) for treating infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clarithromycin Dosage Recommendations

For adults, the recommended dosage of clarithromycin is 500 mg twice daily for most infections, with duration varying from 7-14 days depending on the specific infection being treated. 1, 2

Standard Adult Dosing

  • For immediate-release formulation: 500 mg twice daily (total 1 g per day) 1, 3
  • For extended-release formulation: 1 g once daily (two 500 mg tablets), should be taken with food 1, 4
  • Extended-release tablets should be swallowed whole; do not chew, break or crush 1

Infection-Specific Dosing and Duration

Respiratory Infections

  • Acute bacterial exacerbation of chronic bronchitis: 1 g extended-release daily for 7 days 1
  • Community-acquired pneumonia: 1 g extended-release daily for 7 days 1
  • Acute maxillary sinusitis: 1 g extended-release daily for 14 days 1

Helicobacter pylori Infection

  • Standard triple therapy: 500 mg twice daily for 14 days (with PPI and amoxicillin or metronidazole) 2
  • Sequential therapy: 500 mg twice daily (during second 5-day period of 10-day regimen) 2

Mycobacterial Infections

  • Mycobacterium avium complex: 500 mg twice daily with ethambutol (15 mg/kg daily) 2

Lyme Disease

  • 500 mg twice daily for 14-21 days (for patients intolerant to first-line agents) 2

Pertussis (Whooping Cough)

  • Adults: 1 g per day in two divided doses for 7 days 2
  • Children >1 month: 15 mg/kg per day (maximum: 1 g per day) in 2 divided doses for 7 days 2
  • Not recommended for infants <1 month of age 2

Dosage Adjustments

Renal Impairment

  • Moderate impairment (CrCl 30-60 mL/min): Reduce dosage by 50% 1, 5
  • Severe impairment (CrCl <30 mL/min): Reduce dosage by 50-75% 1, 5
  • For patients on atazanavir or ritonavir with renal impairment: Reduce dosage by 50-75% 1

Drug Interactions

  • Reduce clarithromycin dose by 50% when co-administered with atazanavir 1
  • Consider dose reduction when used with CYP3A inhibitors (e.g., ritonavir) 1, 5
  • Rifabutin toxicity is common when combined with clarithromycin; consider reducing rifabutin dose 2

Pediatric Dosing

  • Children >1 month: 15 mg/kg/day divided into 2 doses (maximum 1 g/day) 2
  • For NTM infections in children 1 month-11 years: 7.5 mg/kg twice daily (max 500 mg per dose) 2
  • Weight-based dosing for children 1 month-11 years 2:
    • Under 8 kg: 7.5 mg/kg twice daily
    • 8-11 kg: 62.5 mg twice daily
    • 12-19 kg: 125 mg twice daily
    • 20-29 kg: 187.5 mg twice daily
    • 30-40 kg: 250 mg twice daily

Important Considerations

  • Clarithromycin is contraindicated in patients with history of hypersensitivity to macrolide antibiotics 2
  • Should not be administered with astemizole, cisapride, pimazole, or terfenadine due to risk of cardiac arrhythmias 2, 5
  • Inhibits cytochrome P450 (CYP3A) enzymes, leading to multiple potential drug interactions 2, 5
  • Common adverse effects include gastrointestinal symptoms (abdominal pain, diarrhea, nausea, vomiting, and taste perversion) 2, 4
  • Extended-release formulation may have better gastrointestinal tolerability than immediate-release 4
  • Take extended-release tablets with food to maximize bioavailability 4

Monitoring

  • ECG monitoring recommended at baseline and after 2 weeks for patients at risk of QT prolongation 2
  • Consider audiometry at baseline and if symptoms of hearing loss develop 2
  • Routine monitoring of complete blood count, renal and liver function tests during treatment 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.